These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 12686467

  • 1. The reduction in hepatic insulin clearance after oral glucose is not mediated by gastric inhibitory polypeptide (GIP).
    Meier JJ, Gallwitz B, Siepmann N, Holst JJ, Deacon CF, Schmidt WE, Nauck MA.
    Regul Pept; 2003 May 15; 113(1-3):95-100. PubMed ID: 12686467
    [Abstract] [Full Text] [Related]

  • 2. Similar insulin secretory response to a gastric inhibitory polypeptide bolus injection at euglycemia in first-degree relatives of patients with type 2 diabetes and control subjects.
    Meier JJ, Nauck MA, Siepmann N, Greulich M, Holst JJ, Deacon CF, Schmidt WE, Gallwitz B.
    Metabolism; 2003 Dec 15; 52(12):1579-85. PubMed ID: 14669159
    [Abstract] [Full Text] [Related]

  • 3. Insulinotropic properties of synthetic human gastric inhibitory polypeptide in man: interactions with glucose, phenylalanine, and cholecystokinin-8.
    Nauck M, Schmidt WE, Ebert R, Strietzel J, Cantor P, Hoffmann G, Creutzfeldt W.
    J Clin Endocrinol Metab; 1989 Sep 15; 69(3):654-62. PubMed ID: 2668324
    [Abstract] [Full Text] [Related]

  • 4. Reduction of hepatic insulin clearance after oral glucose ingestion is not mediated by glucagon-like peptide 1 or gastric inhibitory polypeptide in humans.
    Meier JJ, Holst JJ, Schmidt WE, Nauck MA.
    Am J Physiol Endocrinol Metab; 2007 Sep 15; 293(3):E849-56. PubMed ID: 17609256
    [Abstract] [Full Text] [Related]

  • 5. Gastric inhibitory polypeptide does not inhibit gastric emptying in humans.
    Meier JJ, Goetze O, Anstipp J, Hagemann D, Holst JJ, Schmidt WE, Gallwitz B, Nauck MA.
    Am J Physiol Endocrinol Metab; 2004 Apr 15; 286(4):E621-5. PubMed ID: 14678954
    [Abstract] [Full Text] [Related]

  • 6. Preservation of the incretin effect after orthotopic pancreas transplantation in inbred rats.
    Kissler HJ, Gepp H, Schmiedl A, Schwille PO.
    Metabolism; 1999 May 15; 48(5):645-50. PubMed ID: 10337868
    [Abstract] [Full Text] [Related]

  • 7. Insulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance.
    Rask E, Olsson T, Söderberg S, Holst Jj Jj, Tura A, Pacini G, Ahrén B.
    Metabolism; 2004 May 15; 53(5):624-31. PubMed ID: 15131768
    [Abstract] [Full Text] [Related]

  • 8. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
    Nauck MA, Bartels E, Orskov C, Ebert R, Creutzfeldt W.
    J Clin Endocrinol Metab; 1993 Apr 15; 76(4):912-7. PubMed ID: 8473405
    [Abstract] [Full Text] [Related]

  • 9. Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes.
    Nauck MA, El-Ouaghlidi A, Gabrys B, Hücking K, Holst JJ, Deacon CF, Gallwitz B, Schmidt WE, Meier JJ.
    Regul Pept; 2004 Nov 15; 122(3):209-17. PubMed ID: 15491793
    [Abstract] [Full Text] [Related]

  • 10. Secretion of incretin hormones and the insulinotropic effect of gastric inhibitory polypeptide in women with a history of gestational diabetes.
    Meier JJ, Gallwitz B, Askenas M, Vollmer K, Deacon CF, Holst JJ, Schmidt WE, Nauck MA.
    Diabetologia; 2005 Sep 15; 48(9):1872-81. PubMed ID: 16010522
    [Abstract] [Full Text] [Related]

  • 11. Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects.
    Vilsbøll T, Krarup T, Madsbad S, Holst JJ.
    Regul Pept; 2003 Jul 15; 114(2-3):115-21. PubMed ID: 12832099
    [Abstract] [Full Text] [Related]

  • 12. Effects of atropine and gastric inhibitory polypeptide on hepatic glucose uptake and insulin extraction in conscious dogs.
    Chap Z, Ishida T, Chou J, Lewis R, Hartley C, Entman M, Field JB.
    J Clin Invest; 1985 Sep 15; 76(3):1174-81. PubMed ID: 3900134
    [Abstract] [Full Text] [Related]

  • 13. Augmentation of alimentary insulin secretion despite similar gastric inhibitory peptide (GIP) responses in juvenile obesity.
    Heptulla RA, Tamborlane WV, Cavaghan M, Bronson M, Limb C, Ma YZ, Sherwin RS, Caprio S.
    Pediatr Res; 2000 May 15; 47(5):628-33. PubMed ID: 10813588
    [Abstract] [Full Text] [Related]

  • 14. The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-37) in normal and diabetic subjects.
    Elahi D, McAloon-Dyke M, Fukagawa NK, Meneilly GS, Sclater AL, Minaker KL, Habener JF, Andersen DK.
    Regul Pept; 1994 Apr 14; 51(1):63-74. PubMed ID: 8036284
    [Abstract] [Full Text] [Related]

  • 15. Dissociated effects of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide-1 on beta-cell secretion and insulin clearance in mice.
    Pacini G, Thomaseth K, Ahrén B.
    Metabolism; 2010 Jul 14; 59(7):988-92. PubMed ID: 20153002
    [Abstract] [Full Text] [Related]

  • 16. Effect of Miglitol (Bay m1099), a new alpha-glucosidase inhibitor, on glucose, insulin, C-peptide and GIP responses to an oral sucrose load in patients with post-prandial hypoglycaemic symptoms.
    Renard E, Parer-Richard C, Richard JL, Jureidini S, Orsetti A, Mirouze J.
    Diabete Metab; 1991 Jul 14; 17(3):355-62. PubMed ID: 1884880
    [Abstract] [Full Text] [Related]

  • 17. Effect of synthetic human glucose-dependent insulinotropic polypeptide (hGIP) on the release of insulin in man.
    Füessl HS, Yiangou Y, Ghatei MA, Goebel FD, Bloom SR.
    Eur J Clin Invest; 1990 Oct 14; 20(5):525-9. PubMed ID: 2124984
    [Abstract] [Full Text] [Related]

  • 18. Modifications of gastric inhibitory polypeptide (GIP) secretion in man by a high-fat diet.
    Morgan LM, Hampton SM, Tredger JA, Cramb R, Marks V.
    Br J Nutr; 1988 May 14; 59(3):373-80. PubMed ID: 3293660
    [Abstract] [Full Text] [Related]

  • 19. The incretin effect does not differ in trained and untrained, young, healthy men.
    Lund MT, Dalby S, Hartmann B, Helge J, Holst JJ, Dela F.
    Acta Physiol (Oxf); 2014 Mar 14; 210(3):565-72. PubMed ID: 24354574
    [Abstract] [Full Text] [Related]

  • 20. Secretion, degradation, and elimination of glucagon-like peptide 1 and gastric inhibitory polypeptide in patients with chronic renal insufficiency and healthy control subjects.
    Meier JJ, Nauck MA, Kranz D, Holst JJ, Deacon CF, Gaeckler D, Schmidt WE, Gallwitz B.
    Diabetes; 2004 Mar 14; 53(3):654-62. PubMed ID: 14988249
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.